Geode Capital Management’s NanoViricides NNVC Stock Holding History

Geode Capital Management’s Portfolio NNVC Stock Details NNVC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$298K	Sell	216,022 -9,359	-4%	-$12.8K	﹤0.01%	3782
2026 Q1	$206K	Buy	225,381 +51,010	+29%	+$53.4K	﹤0.01%	3902
2025 Q4	$197K	Buy	174,371 +14,944	+9%	+$21K	﹤0.01%	3908
2025 Q3	$228K	Buy	159,427 +1,433	+0.9%	+$2.15K	﹤0.01%	3880
2025 Q2	$221K	Buy	157,994 +3,404	+2%	+$4.65K	﹤0.01%	3842
2025 Q1	$181K	Buy	154,590 +11,277	+8%	+$14.3K	﹤0.01%	3881
2024 Q4	$205K	Buy	143,313 +31,956	+29%	+$45.9K	﹤0.01%	3896
2024 Q3	$167K	Buy	111,357 +2,829	+3%	+$5.25K	﹤0.01%	3960
2024 Q2	$187K	Sell	108,528 -961	-0.9%	-$1.71K	﹤0.01%	3934
2024 Q1	$127K	Hold	109,489	–	–	﹤0.01%	4084
2023 Q4	$112K	Hold	109,489	–	–	﹤0.01%	4151
2023 Q3	$147K	Sell	109,489 -1,804	-2%	-$2.55K	﹤0.01%	4104
2023 Q2	$128K	Hold	111,293	–	–	﹤0.01%	4238
2023 Q1	$130K	Hold	111,293	–	–	﹤0.01%	4239
2022 Q4	$123K	Sell	111,293 -344	-0.3%	-$537	﹤0.01%	4315
2022 Q3	$193K	Buy	111,637 +1,537	+1%	+$3.35K	﹤0.01%	4237
2022 Q2	$206K	Buy	110,100 +1,600	+1%	+$2.94K	﹤0.01%	4245
2022 Q1	$226K	Hold	108,500	–	–	﹤0.01%	4315
2021 Q4	$403K	Buy	108,500 +39,782	+58%	+$181K	﹤0.01%	4159
2021 Q3	$318K	Buy	68,718 +3,447	+5%	+$14.4K	﹤0.01%	4243
2021 Q2	$302K	Hold	65,271	–	–	﹤0.01%	4165
2021 Q1	$308K	Buy	65,271 +25,157	+63%	+$114K	﹤0.01%	3978
2020 Q4	$115K	Hold	40,114	–	–	﹤0.01%	4030
2020 Q3	$154K	Hold	40,114	–	–	﹤0.01%	3796
2020 Q2	$300K	Hold	40,114	–	–	﹤0.01%	3542
2020 Q1	$230K	Buy	+40,114	New	+$283K	﹤0.01%	3506
2019 Q3	–	Sell	-8,799	Closed	-$42K	–	4223
2019 Q2	$42K	Hold	8,799	–	–	﹤0.01%	4098
2019 Q1	$47K	Hold	8,799	–	–	﹤0.01%	4030
2018 Q4	$35K	Hold	8,799	–	–	﹤0.01%	4042
2018 Q3	$63K	Hold	8,799	–	–	﹤0.01%	4001
2018 Q2	$77K	Hold	8,799	–	–	﹤0.01%	3923
2018 Q1	$144K	Hold	8,799	–	–	﹤0.01%	3771
2017 Q4	$154K	Hold	8,799	–	–	﹤0.01%	3733
2017 Q3	$200K	Hold	8,799	–	–	﹤0.01%	3672
2017 Q2	$237K	Hold	8,799	–	–	﹤0.01%	3617
2017 Q1	$197K	Hold	8,799	–	–	﹤0.01%	3657
2016 Q4	$188K	Hold	8,799	–	–	﹤0.01%	3638
2016 Q3	$297K	Hold	8,799	–	–	﹤0.01%	3458
2016 Q2	$281K	Hold	8,799	–	–	﹤0.01%	3451
2016 Q1	$385K	Hold	8,799	–	–	﹤0.01%	3357
2015 Q4	$207K	Hold	8,799	–	–	﹤0.01%	3672
2015 Q3	$209K	Hold	8,799	–	–	﹤0.01%	3670
2015 Q2	$304K	Sell	8,799 -1,730	-16%	-$65.9K	﹤0.01%	3422
2015 Q1	$473K	Hold	10,529	–	–	﹤0.01%	3215
2014 Q4	$572K	Buy	10,529 +302	+3%	+$20K	﹤0.01%	3124
2014 Q3	$613K	Hold	10,227	–	–	﹤0.01%	3065
2014 Q2	$865K	Buy	10,227 +1,428	+16%	+$101K	﹤0.01%	2880
2014 Q1	$563K	Buy	8,799 +7,993	+992%	+$683K	﹤0.01%	3099
2013 Q4	$77K	Buy	+806	New	+$82.9K	﹤0.01%	3642

Other funds holding NNVC

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

CCM

Connective Capital Management Palo Alto, California $142M AUM 51.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

MFS

Miller Financial Services Marshall, Michigan $124M AUM 17.62% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management's NNVC Position: Q2 2026 in Review

Geode Capital Management reduced its NanoViricides (NNVC) stake by 4.2% in Q2 2026, selling an estimated $12.8K and leaving 216,022 shares worth $298K. The position accounts for ﹤0.01% of the portfolio, ranked #3782.

Geode Capital Management first reported a position in NNVC in Q4 2013 and has held it in 49 quarters since. The position peaked at $865K in Q2 2014. 48 funds tracked by Wall St. Rank hold NNVC as of Q2 2026.

Geode Capital Management held 216,022 shares of NanoViricides worth $298K as of Q2 2026.
Geode Capital Management sold 9,359 NanoViricides shares in Q2 2026, an estimated $12.8K.
NanoViricides made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #3782 holding.
Geode Capital Management first reported a position in NanoViricides in Q4 2013 and has held it in 49 quarters since.
Geode Capital Management's NanoViricides position peaked at $865K in Q2 2014.
48 funds tracked by Wall St. Rank held NanoViricides as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.